Diagnostic utility of PAX8, TTF-1 and napsin A for discriminating metastatic carcinoma from primary adenocarcinoma of the lung

References

• Albadine R, Schultz L, Illei P, Ertoy D, Hicks J, Sharma R, Epstein JI, Netto GJ (2010) PAX8 (+)/p63 (−) immunostaining pattern in renal collecting duct carcinoma (CDC): a useful immunoprofile in the differential diagnosis of CDC versus urothelial carcinoma of upper urinary tract. Am. J. Surg. Pathol. 34: 965–969.
   PubMedGoogle Scholar
• Bishop JA, Sharma R, Illei PB (2010) Napsin A and thyroid transcription factor-1 expression in carcinomas of the lung, breast, pancreas, colon, kidney, thyroid, and malignant mesothelioma. Hum. Pathol. 41: 20–25.
   PubMed Web of Science ®Google Scholar
• Boggaram V (2009) Thyroid transcription factor-1 (TTF-1/Nkx2.1/TITF1) gene regulation in the lung. Clin. Sci. (Lond.) 116: 27–35.
   PubMed Web of Science ®Google Scholar
• Chuman Y, Bergman A, Ueno T, Saito S, Sakaguchi K, Alaiya AA, Franzén B, Bergman T, Arnott D, Auer G, Appella E, Jörnvall H, Linder S (1999) Napsin A, a member of the aspartic protease family, is abundantly expressed in normal lung and kidney tissue and is expressed in lung adenocarcinomas. FEBS Lett. 462: 129–134.
   PubMedGoogle Scholar
• Comperat E, Zhang F, Perrotin C, Molina T, Magdeleinat P, Marmey B, Regnard JF, Audouin J, Camilleri-Broet S (2005) Variable sensitivity and specificity of TTF-1 antibodies in lung metastatic adenocarcinoma of colorectal origin. Mod. Pathol. 18: 1371–1376.
   PubMed Web of Science ®Google Scholar
• Dejmek A, Naucler P, Smedjeback A, Kato H, Maeda M, Yashima K, Maeda J, Hirano T (2007) Napsin A (TA02) is a useful alternative to thyroid transcription factor-1 (TTF-1) for the identification of pulmonary adenocarcinoma cells in pleural effusions. Diagn. Cytopathol. 35: 493–497.
   PubMed Web of Science ®Google Scholar
• Dressler GR (2009) The specification and maintenance of renal cell types by epigenetic factors. Organogenesis 5: 73–82.
   PubMed Web of Science ®Google Scholar
• Edwards BK, Brown ML, Wingo PA, Howe HL, Ward E, Ries LA, Schrag D, Jamison PM, Jemal A, Wu XC, Friedman C, Harlan L, Warren J, Anderson RN, Pickle LW (2005) Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment. J. Natl. Cancer Inst. 97: 1407–1427.
   PubMed Web of Science ®Google Scholar
• Fabbro D, Di Loreto C, Beltrami CA, Belfiore A, Di Lauro R, Damante G (1994) Expression of thyroid-specific transcription factors TTF-1 and PAX-8 in human thyroid neoplasms. Cancer Res. 54: 4744–4749.
   PubMed Web of Science ®Google Scholar
• Fujiwara M, Taube J, Sharma M, McCalmont TH, Kim J (2010) PAX8 discriminates ovarian metastases from adnexal tumors and other cutaneous metastases. J. Cutan. Pathol. 37: 938–943.
   PubMedGoogle Scholar
• Hirano T, Auer G, Maeda M, Hagiwara Y, Okada S, Ohira T, Okuzawa K, Fujioka K, Franzén B, Hibi N, Seito T, Ebihara Y, Kato H (2000) Human tissue distribution of TA02, which is homologous with a new type of aspartic proteinase, napsin A. Jpn. J. Cancer Res. 91: 1015–1021.
   PubMedGoogle Scholar
• Hirano T, Gong Y, Yoshida K, Kato Y, Yashima K, Maeda M, Nakagawa A, Fujioka K, Ohira T, Ikeda N, Ebihara Y, Auer G, Kato H (2003) Usefulness of TA02 (napsin A) to distinguish primary lung adenocarcinoma from metastatic lung adenocarcinoma. Lung Cancer 41: 155–162.
   PubMed Web of Science ®Google Scholar
• Klingen TA, Chen Y, Gundersen MD, Aas H, Westre B, Sauer T (2010) Thyroid transcription factor-1 positive primary breast cancer: a case report with review of the literature. Diagn. Pathol. 5: 37.
   PubMedGoogle Scholar
• Kubba LA, McCluggage WG, Liu J, Malpica A, Euscher ED, Silva EG, Deavers MT (2008) Thyroid transcription factor-1 expression in ovarian epithelial neoplasms. Mod. Pathol. 21: 485–490.
   PubMed Web of Science ®Google Scholar
• Lotan TL, Ye H, Melamed J, Wu XR, Shih Ie M, Epstein JI (2009) Immunohistochemical panel to identify the primary site of invasive micropapillary carcinoma. Am. J. Surg. Pathol. 33: 1037–1041.
   PubMedGoogle Scholar
• Mittag J, Winterhager E, Bauer K, Grummer R (2007) Congenital hypothyroid female pax8-deficient mice are infertile despite thyroid hormone replacement therapy. Endocrinology 148: 719–725.
   PubMed Web of Science ®Google Scholar
• Nitsch R, Di Dato V, di Gennaro A, de Cristofaro T, Abbondante S, De Felice M, Zannini M, Di Lauro R (2010) Comparative genomics reveals a functional thyroid-specific element in the far upstream region of the PAX8 gene. BMC Genomics 11: 306.
   PubMedGoogle Scholar
• Nonaka D, Tang Y, Chiriboga L, Rivera M, Ghossein R (2007) Diagnostic utility of thyroid transcription factors Pax8 and TTF-2 (FoxE1) in thyroid epithelial neoplasms. Mod. Pathol. 21:192–200.
   PubMedGoogle Scholar
• Siami K, McCluggage WG, Ordonez NG, Euscher ED, Malpica A, Sneige N, Silva EG, Deavers MT (2007) Thyroid transcription factor-1 expression in endometrial and endocervical adenocarcinomas. Am. J. Surg. Pathol. 31: 1759–1763.
   PubMed Web of Science ®Google Scholar
• Tong GX, Devaraj K, Hamele-Bena D, Yu WM, Turk A, Chen X, Wright JD, Greenebaum E (2010) PAX8: a marker for carcinoma of Mullerian origin in serous effusions. Diagn. Cytopathol. In press.
   Google Scholar
• Tong GX, Yu WM, Beaubier NT, Weeden EM, Hamele-Bena D, Mansukhani MM, O'Toole KM (2009) Expression of PAX8 in normal and neoplastic renal tissues: an immunohistochemical study. Mod. Pathol. 22: 1218–1227.
   PubMedGoogle Scholar
• Travis WD (2002) Pathology of lung cancer. Clin. Chest Med. 23: 65–81, viii.
   PubMed Web of Science ®Google Scholar
• Zhang PJ, Gao HG, Pasha TL, Litzky L, Livolsi VA (2009) TTF-1 expression in ovarian and uterine epithelial neoplasia and its potential significance, an immunohistochemical assessment with multiple monoclonal antibodies and different secondary detection systems. Int. J. Gynecol. Pathol. 28: 10–18.
   PubMedGoogle Scholar
• Ye J, Findeis-Hosey JJ, Yang Q, McMahon LA, Yao JL, Li F, Xu H (2011) Combination of napsin A and TTF-1immunohistochemistry helps in differentiating primary lung adenocarcinoma from metastatic carcinoma in the lung. Appl. Immunohistochem. Mol. Morphol. 19: 313–317.
   PubMedGoogle Scholar